Article
An association of epidermal growth factor receptor mutation subtypes with prognostic prediction and site-specific recurrence in advanced stage lung cancer patients.
Molecular biology reports - 1 Jun 2023
Joshi Jigna, Pandit Apexa, Tarapara Bhoomi, Patel Hitarth, Bhavnagari Hunayna, Panchal Harsha, Shah Franky D
Abstract excerpt
BACKGROUND: Concerning the different clinical behavior of epidermal growth factor receptor (EGFR) subtypes in advanced-stage lung cancer patients, the current study aimed to evaluate the clinical, pathological, and prognostic significance of EGFR mutation subtypes, and treatment response in patients with advanced-stage lung cancer. METHODS AND RESULTS: A retrospective study enrolled a total of 346 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
